Sodium chlorideCAS# 7647-14-5 |
- S0859
Catalog No.:BCC1914
CAS No.:1019331-10-2
- Nav1.7 inhibitor
Catalog No.:BCC4191
CAS No.:1355631-24-1
- Riluzole
Catalog No.:BCC3849
CAS No.:1744-22-5
- Flecainide acetate
Catalog No.:BCC1578
CAS No.:54143-56-5
- Dibucaine (Cinchocaine) HCl
Catalog No.:BCC3760
CAS No.:61-12-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 7647-14-5 | SDF | Download SDF |
PubChem ID | 5234 | Appearance | Powder |
Formula | NaCl | M.Wt | 58.44 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 500 mM in water | ||
Chemical Name | sodium;chloride | ||
SMILES | [Na+].[Cl-] | ||
Standard InChIKey | FAPWRFPIFSIZLT-UHFFFAOYSA-M | ||
Standard InChI | InChI=1S/ClH.Na/h1H;/q;+1/p-1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Commonly used laboratory reagent |
Sodium chloride Dilution Calculator
Sodium chloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 17.1116 mL | 85.5578 mL | 171.1157 mL | 342.2313 mL | 427.7892 mL |
5 mM | 3.4223 mL | 17.1116 mL | 34.2231 mL | 68.4463 mL | 85.5578 mL |
10 mM | 1.7112 mL | 8.5558 mL | 17.1116 mL | 34.2231 mL | 42.7789 mL |
50 mM | 0.3422 mL | 1.7112 mL | 3.4223 mL | 6.8446 mL | 8.5558 mL |
100 mM | 0.1711 mL | 0.8556 mL | 1.7112 mL | 3.4223 mL | 4.2779 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Dihydroxyaflavinine
Catalog No.:BCN7387
CAS No.:76410-56-5
- Euphorbia factor Ti2
Catalog No.:BCN3782
CAS No.:64180-96-7
- (1S)-(+)-Menthyl chloroformate
Catalog No.:BCN4972
CAS No.:7635-54-3
- Latrunculin A
Catalog No.:BCC7830
CAS No.:76343-93-6
- DL-AP5
Catalog No.:BCC6552
CAS No.:76326-31-3
- Sodium Nitrite
Catalog No.:BCC4723
CAS No.:7632-00-0
- Olaparib (AZD2281, Ku-0059436)
Catalog No.:BCC2206
CAS No.:763113-22-0
- Polyphyllin G
Catalog No.:BCN1054
CAS No.:76296-75-8
- Polyphyllin F
Catalog No.:BCN2589
CAS No.:76296-74-7
- Polyphyllin E
Catalog No.:BCN2588
CAS No.:76296-73-6
- Polyphyllin II
Catalog No.:BCN1052
CAS No.:76296-72-5
- Polyphyllin C
Catalog No.:BCN2587
CAS No.:76296-71-4
- Cesium chloride
Catalog No.:BCC2399
CAS No.:7647-17-8
- Effusanin E
Catalog No.:BCN3234
CAS No.:76470-15-0
- Effusanin B
Catalog No.:BCN3391
CAS No.:76470-16-1
- Kuwanon H
Catalog No.:BCN2945
CAS No.:76472-87-2
- Morachalcone A
Catalog No.:BCN4311
CAS No.:76472-88-3
- Dihydrocurcumin
Catalog No.:BCN6297
CAS No.:76474-56-1
- Galeopsin
Catalog No.:BCN7358
CAS No.:76475-16-6
- Croverin
Catalog No.:BCN2518
CAS No.:76475-17-7
- 8-Acetoxy-15,16-epoxy-8,9-secolabda-13(16),14-diene-7,9-dione
Catalog No.:BCN7409
CAS No.:76475-32-6
- Ligustrazine Hydrochloride
Catalog No.:BCN1009
CAS No.:76494-51-4
- 15,16-Dinor-8(17),11-labdadien-13-one
Catalog No.:BCN4312
CAS No.:76497-69-3
- 10-Hydroxy-2-decenoic acid
Catalog No.:BCN2654
CAS No.:765-01-5
Insights into metabolism and sodium chloride adaptability of carbaryl degrading halotolerant Pseudomonas sp. strain C7.[Pubmed:28374062]
Arch Microbiol. 2017 Aug;199(6):907-916.
Pseudomonas sp. strain C7 isolated from sediment of Thane creek near Mumbai, India, showed the ability to grow on glucose and carbaryl in the presence of 7.5 and 3.5% of NaCl, respectively. It also showed good growth in the absence of NaCl indicating the strain to be halotolerant. Increasing salt concentration impacted the growth on carbaryl; however, the specific activity of various enzymes involved in the metabolism remained unaffected. Among various enzymes, 1-naphthol 2-hydroxylase was found to be sensitive to chloride as compared to carbaryl hydrolase and gentisate 1,2-dioxygenase. The intracellular concentration of Cl(-) ions remained constant (6-8 mM) for cells grown on carbaryl either in the presence or absence of NaCl. Thus the ability to adapt to the increasing concentration of NaCl is probably by employing chloride efflux pump and/or increase in the concentration of osmolytes as mechanism for halotolerance. The halotolerant nature of the strain will be beneficial to remediate carbaryl from saline agriculture fields, ecosystems and wastewaters.
Influence of sodium chloride content in electrolyte solution on electrochemical impedance measurements of human dentin.[Pubmed:28348614]
Dent Res J (Isfahan). 2017 Jan-Feb;14(1):25-31.
BACKGROUND: The aim of this study was to investigate the influence of Sodium chloride (NaCl) content in electrolyte solution on electrochemical impedance measurements of human dentin by employing electrochemical impedance spectroscopy. MATERIALS AND METHODS: Dentin samples were prepared from extracted molars. Electrochemical impedance measurements were carried out over a wide frequency range (0.01Hz-10MHz). After measurements, samples were characterized using scanning electron microscopy. RESULTS: Electrochemical impedance measurements showed that the mean values of dentin electrical resistance were 4284, 2062, 1336, 53 and 48kOmega at different NaCl contents in electrolyte solution. One-way ANOVA test of mean values of dentin electrical resistance revealed a significant difference (P < 0.0001) as a function of NaCl content in electrolyte solution. Comparing electrical resistance values of dentin samples at 0.05% w/v and 0.9% w/v concentrations were found to be significantly different (P < 0.05 at 95% confidence level). Scanning electron microscopy revealed structure of dentin sample with intertubular dentin matrix and distribution of patent dentinal tubules. CONCLUSION: This in vitro study indicated, through electrochemical impedance spectroscopy measurements, that electrical resistance of dentin was affected by the concentration of NaCl in electrolyte solution. It is clear from the current study that NaCl concentration in electrolyte solution has a marked influence on dentin electrical resistance. Therefore, this baseline data need to be considered in any future study on dental samples.
Incidence of Adverse Events During Peripheral Administration of Sodium Chloride 3.[Pubmed:28372499]
J Intensive Care Med. 2018 Jan;33(1):48-53.
PURPOSE: Traditionally, Sodium chloride 3% has been administered via a central venous line (CVL) because of the perceived risk of infiltration and tissue injury due to its high osmolarity. In clinical practice, Sodium chloride 3% is commonly administered through peripheral venous catheters (PVCs) given the necessity of timely administration. However, there is no published data on the safety of administering Sodium chloride 3% through PVCs in the adult population. The objective of this study was to evaluate the safety of peripheral venous administration of Sodium chloride 3%. MATERIALS AND METHODS: A retrospective review was conducted in patients who received Sodium chloride 3% in the intensive care unit (ICU). Patients were excluded if they had a CVL for the entire duration of the infusion or younger than 18 years at the time of administration. Baseline patient and infusion characteristics were collected. Infusion-related adverse events (IRAEs) were recorded, graded, and interventions required were noted. RESULTS: A total of 66 patients were included in the analysis. The most common indication was hyponatremia and majority of the patients were managed in the neurosurgical ICU. The most common risk factor for IRAEs was the presence of altered mental status. Four patients experienced an IRAE at an event rate of 6.1%. Patients who experienced an IRAE ranged from 38 to 82 years old. The IRAEs were grade 1 in severity, managed conservatively with removal of the PVC, and 2 of the 4 patients had their infusions restarted peripherally. The time to initial IRAE ranged from 2 to 94 hours. For the entire cohort, hospital and ICU length of stay were 8 and 4 days, respectively. CONCLUSIONS: The rate of IRAEs related to the infusion of Sodium chloride 3% through PVCs appears to be similar to those reported with other hyperosmotic agents and could be considered for patients who need time-sensitive therapy.